The Use of Botulinium Toxin as a Nonsurgical Adjuvant in the Closed Management of Condylar/Subcondylar Fractures

Ellis E. and Throckmorton G.S.: Treatment of mandibular
condylar process fractures: Biological considerations. J.
Oral Maxillofac. Surg., 63: 115-34, 2005.
2- Tasanen A. and Lamberg M.A.: Trans-osseous wiring in
the treatment of condylar fractures of the mandible. J.
Maxillofac. Surg., 4: 200-6, 1976.
3- Ellis E. 3rd, Moos K.F. and El-Attar A.: Ten years of
mandibular fractures: An analysis of 2,137 cases. Oral
Surg. Oral Med. Oral Pathol., 59: 120-9, 1985.
4- Vural E.: Treatment of adult subcondylar mandibular
fractures: Closed vs open vs endoscopic approach. Arch.
Otolaryngol. Head Neck Surg., 130: 228-30, 2004.
5- Brandt M.T. and Haug R.H.: Open versus closed reduction
of adult mandibular condyle fractures: A review of the
literature regarding the evolution of current thoughts on
management. J. Oral Maxillofac. Surg., 61: 1324-32,
2003.
6- Merlet F.L., Grimaud F., Pace R., Mercier J.M., Poisson
M., Pare A. and Corre P.: Outcomes of functional treatment
versus open reduction and internal fixation of condylar
mandibular fracture with articular impact: A retrospective
study of 83 adults, Journal of Stomatology, Oral and
Maxillofacial Surgery, 119 (1): 8-15, 2018.
7- Rozeboom A.V.J., Dubois L., Bos R.R.M., Spijker R. and
Lange J.D.: Closed treatment of unilateral mandibular
condyle fractures in adults: A systematic review, International
Journal of Oral and Maxillofacial Surgery, 46 (4):
456-64, 2017.
8- Clark G.T.: The management of oromandibular motor
disorders and facial spasms with injections of botulinum
toxin. Phys. Med. Rehabil. Clin. N. Am., 14: 727-48,
2003.
9- Lang A.M.: Botulinum toxin therapy for myofascial pain
disorders. Curr. Pain Headache Rep., 6: 355-60, 2002.
10- Freund B., Schwartz M. and Symington J.M.: Botulinum
toxin: New treatment for temporomandibular disorders.
Br. J. Oral Maxillofac. Surg., 38: 466-71, 2000.
11- Lovell B.V. and Marmura M.J.: New therapeutic developments
in chronic migraine. Curr. Opin. Neurol., 23: 254-
8, 2010.
12- Bhogal P.S., Hutton A. and Monaghan A.: A review of
the current uses of Botox for dentally-related procedures.
Dent. Update, 33: 165-8, 2006.
13- Daelen B., Thorwirth V. and Koch A.: Treatment of
recurrent dislocation of the temporomandibular joint with
type A botulinum toxin. Int. J. Oral Maxillofac. Surg.,
26: 458-60, 1997.
14- Moore A.P. and Wood G.D.: Medical treatment of recurrent
temporomandibular joint dislocation using botulinum
toxin A. Br. Dent. J., 183: 415-7, 1997.
15- Ziegler C.M., Haag C. and Mühling J.: Treatment of
recurrent temporomandibular joint dislocation with intramuscular
botulinum toxin injection. Clin. Oral Investig.,
7: 52-5, 2003.
16- Fu K.Y., Chen H.M., Sun Z.P., Zhang Z.K. and Ma X.C.:
Long-term efficacy of botulinum toxin type A for the
treatment of habitual dislocation of the temporomandibular
joint. Br. J. Oral Maxillofac. Surg., 48: 281-4, 2010.
17- Halil I.C., Aycan K., Muge A. and Mehmet E.M.: Botulinum
Toxin in Closed Treatment of Mandibular Condylar
Fracture, Annals of Plastic Surgery, 58 (5): 474-8, 2007.
18- Bbagol A., Singb V., Kumar I. and Verma A.: Prospective
evaluation of a new classification system for the management
of mandibular subcondylar fractures J. Oral Maxil-
Lofac. Surg., 69: 1159-65, 2011.
19- Ghasemzadeh A., Mundinger G.S., Swanson E.W., Utria
A.F. and Dorafshar A.H.: Treatment of Pediatric Condylar
Fractures: A 20-Year Experience, Plast. and Reconstr.
Surg., 136 (6): 1278-88, 2015.
306 Vol. 43, No. 2 / The Use of Botulinium Toxin as a Nonsurgical Adjuvant
20- Welch M.J., Purkiss J.R. and Foster K.A.: Sensitivity of
embryonic rat dorsal root ganglia neurons to Clostridium
botulinum neurotoxins. Toxicon, 38 (8): 245-58, 2000.
21- Lu D.W. and Lippitz J.: Complications of botulinum
neurotoxin. Dis. Mon., 55 (4): 198-211, 2009.
22- Schames J., Dov Prero Y., Schames D., Schames M.,
Gabriel W. and Reed R.: Uncontrollable distant effects
of botulinum neurotoxin injections. J. Calif. Dent. Assoc.,
37: 44-5, 2009.
23- Blitzer A. and Sulica L.: Botulinum toxin: Basic science
and clinical uses in otolaryngology. Laryngoscope, 111
(2): 218-26, 2001.
24- Murray G.M., Orfanos T., Chan J.Y., Wanigaratne K. and
Klineberg I.J.: Electromyographic activity of the human
lateral pterygoid muscle during contralateral and protrusive
jaw movements. Arch. Oral Biol., 44: 269-85, 1999.
25- Murray G.M., Bhutada M., Peck C.C., Phanachet I., Sae-
Lee D. and Whittle T.: The human lateral pterygoid muscle.
Arch. Oral Boil., 52: 377-80, 2007.
26- Aoki K.R. and Guyer B.: Botulinum toxin type A and
other botulinum toxin serotypes: A comparative review
of biochemical and pharmacological actions. Eur. J.
Neurol., 8: 21-9, 2001.
27- Teixeira A.C., Luz J.G., Araujo V.C. and Araujo N.S.:
Healing of the displaced condylar process fracture: An
experimental study. J. Craniomaxillofac. Surg., 26: 326-
30, 1998.
28- Takarada T.: Anatomical studies on the maxillary artery.
J. Tokyo Dent. Coll. Soc., 53: 1-20, 1958.
29- Talwar R.M., Ellis E. 3rd and Throckmorton G.S.: Adaptations
of the masticatory system after bilateral fractures
of the mandibular condylar process. J. Oral Maxillofac.
Surg., 56: 430-9, 1998.
30- Villarreal P.M., Monje F., Junquera L.M., et al.: Mandibular
condyle fractures: Determinants of treatment and outcome.
J. Oral Maxillofac. Surg., 62: 155-63, 2004.
31- Lindahl L.: Condylar fractures of the mandible, I:
Classification and relation to age, occlusion, and concomitant
injuries of teeth and teeth supporting structures, and
fractures of the mandibular body. Int. J. Oral Surg., 6:
12-21, 1977.